Rostec Corporation intends to start exporting medicinal products and medical devices to the Republic of Uzbekistan. A corresponding memorandum was signed by Nacimbio (part of Rostec) and Republican Foreign Economic Enterprise Uzmedexport.
As part of their cooperation, Nacimbio and Uzmedexport will strengthen the collaboration at the expert level, develop priority projects, and create conditions for implementing innovative technology and products.
“The strategy of Rostec Corporation, which includes our holding company, provides for the annual revenue growth of 17% until 2025. The Corporation plans to reach this figure by introducing new products, increasing exports, and entering new markets. Syntez, an enterprise that is part of Nacimbio, is already exporting its products to 15 countries and this is what largely allows it to demonstrate top financial performance,” said Andrey Zagorsky, the General Director of Nacimbio. “The products of Nacimbio are widely represented in the Russian market and we plan to actively develop our own export competencies. For example, this includes starting the exports of drugs manufactured by Fort, a plant with the capacity that allows to increase the output for deliveries within several months.”
“We are pleased to have an opportunity for a partnership with reliable Russian company representing the pharmaceutical block of Rostec, the largest state corporation. I am convinced that the cooperation between Nacimbio and Uzmedexport will become a clear example of fruitful relations between Russia and Uzbekistan in the area of supplying the medicines and medical devices,” said Bahtiyer Umarov, the General Director of Uzmedexport.